• レポートコード:QY2108PAL8888 • 出版社/出版日:QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、157ページ • 納品方法:Eメール(納期:1日) • 産業分類:医薬品 |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の当調査資料ではグローバルにおけるメサラジンの市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、メサラジンの種類別市場規模(純度≥97%、純度≥98%、純度≥99%)、用途別市場規模(錠剤、カプセル、ペレット、顆粒、坐剤、浣腸、その他)も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のメサラジン市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるメサラジンの種類別市場規模(2016年-2027年):純度≥97%、純度≥98%、純度≥99% ・世界におけるメサラジンの用途別市場規模(2016年-2027年):錠剤、カプセル、ペレット、顆粒、坐剤、浣腸、その他 ・メサラジンの中国市場分析 - メサラジンの中国市場規模(2016年-2027年) - 中国におけるメサラジンの主要プレイヤー別市場シェア - 中国におけるメサラジンの種類別市場規模:純度≥97%、純度≥98%、純度≥99% - 中国におけるメサラジンの用途別市場規模:錠剤、カプセル、ペレット、顆粒、坐剤、浣腸、その他 ・メサラジンの北米市場(2016年-2027年) ・メサラジンのヨーロッパ市場(2016年-2027年) ・メサラジンのアジア太平洋市場(2016年-2027年) ・メサラジンの中南米市場(2016年-2027年) ・メサラジンの中東・アフリカ市場(2016年-2027年) ・主要プレイヤーの情報:PharmaZell、Syntese A/S、Cambrex Corporation、Divis Laboratories、Chemi SpA、Ipca Laboratories、Hangzhou Brother、Lianyungang Fengheng Biopharm、Lasa Loboratory、Corden Pharma Bergamo、Erregierre SpA、CTX Lifescience、Ishita Active Pharma Ingredients、YC Biotech (Jiangsu)、Xinxiang Tianfeng Fine Chemical ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Mesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn’s disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The industry’s leading manufacturers are Syntese A/S, Divis Laboratories and Cambrex Corporation, which accounted for 24.07%, 12.91% and 6.61% of revenues in 2019, respectively. In terms of regions, the revenue share in Europe is the highest, reaching 46.73% in 2019.
Market Analysis and Insights: Global and China Mesalazine Market
This report focuses on global and China Mesalazine market.
In 2020, the global Mesalazine market size was US$ 142.4 million and it is expected to reach US$ 189 million by the end of 2027, with a CAGR of 4.1% during 2021-2027. In China the Mesalazine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Mesalazine Scope and Market Size
Mesalazine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Mesalazine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Mesalazine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Purity ≥ 97 %
Purity ≥ 98 %
Purity ≥ 99 %
According to the type, purity ≥ 98% is the highest, reaching 48.44% in 2019.
Segment by Application
Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others
Mesalazine tablets has the highest market share in terms of application, at 50.61% in 2019.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
1 Study Coverage
1.1 Mesalazine Product Introduction
1.2 Market by Type
1.2.1 Global Mesalazine Market Size Growth Rate by Type
1.2.2 Purity ≥ 97 %
1.2.3 Purity ≥ 98 %
1.2.4 Purity ≥ 99 %
1.3 Market by Application
1.3.1 Global Mesalazine Market Size Growth Rate by Application
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Pellet and Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mesalazine Market Size, Estimates and Forecasts
2.1.1 Global Mesalazine Revenue 2016-2027
2.1.2 Global Mesalazine Sales 2016-2027
2.2 Global Mesalazine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Mesalazine Historical Market Size by Region (2016-2021)
2.3.1 Global Mesalazine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Mesalazine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Mesalazine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Mesalazine Sales Forecast by Region (2022-2027)
2.4.2 Global Mesalazine Revenue Forecast by Region (2022-2027)
3 Global Mesalazine Competitor Landscape by Players
3.1 Global Top Mesalazine Manufacturers by Sales
3.1.1 Global Mesalazine Sales by Manufacturer (2016-2021)
3.1.2 Global Mesalazine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Mesalazine Manufacturers by Revenue
3.2.1 Key Mesalazine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Mesalazine Revenue by Manufacturers (2016-2021)
3.2.3 Global Mesalazine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Mesalazine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Mesalazine Revenue in 2020
3.2.6 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Mesalazine Price by Manufacturers
3.4 Global Mesalazine Manufacturing Base Distribution, Product Types
3.4.1 Mesalazine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mesalazine Product Type
3.4.3 Date of International Manufacturers Enter into Mesalazine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Mesalazine Market Size by Type (2016-2021)
4.1.1 Global Mesalazine Sales by Type (2016-2021)
4.1.2 Global Mesalazine Revenue by Type (2016-2021)
4.1.3 Mesalazine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Mesalazine Market Size Forecast by Type (2022-2027)
4.2.1 Global Mesalazine Sales Forecast by Type (2022-2027)
4.2.2 Global Mesalazine Revenue Forecast by Type (2022-2027)
4.2.3 Mesalazine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Mesalazine Market Size by Application (2016-2021)
5.1.1 Global Mesalazine Sales by Application (2016-2021)
5.1.2 Global Mesalazine Revenue by Application (2016-2021)
5.1.3 Mesalazine Price by Application (2016-2021)
5.2 Mesalazine Market Size Forecast by Application (2022-2027)
5.2.1 Global Mesalazine Sales Forecast by Application (2022-2027)
5.2.2 Global Mesalazine Revenue Forecast by Application (2022-2027)
5.2.3 Global Mesalazine Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Mesalazine Market Size YoY Growth 2016-2027
6.1.1 China Mesalazine Sales YoY Growth 2016-2027
6.1.2 China Mesalazine Revenue YoY Growth 2016-2027
6.1.3 China Mesalazine Market Share in Global Market 2016-2027
6.2 China Mesalazine Market Size by Players (International and Local Players)
6.2.1 China Top Mesalazine Players by Sales (2016-2021)
6.2.2 China Top Mesalazine Players by Revenue (2016-2021)
6.3 China Mesalazine Historic Market Review by Type (2016-2021)
6.3.1 China Mesalazine Sales Market Share by Type (2016-2021)
6.3.2 China Mesalazine Revenue Market Share by Type (2016-2021)
6.3.3 China Mesalazine Price by Type (2016-2021)
6.4 China Mesalazine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Mesalazine Sales Forecast by Type (2022-2027)
6.4.2 China Mesalazine Revenue Forecast by Type (2022-2027)
6.4.3 China Mesalazine Price Forecast by Type (2022-2027)
6.5 China Mesalazine Historic Market Review by Application (2016-2021)
6.5.1 China Mesalazine Sales Market Share by Application (2016-2021)
6.5.2 China Mesalazine Revenue Market Share by Application (2016-2021)
6.5.3 China Mesalazine Price by Application (2016-2021)
6.6 China Mesalazine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Mesalazine Sales Forecast by Application (2022-2027)
6.6.2 China Mesalazine Revenue Forecast by Application (2022-2027)
6.6.3 China Mesalazine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Mesalazine Market Size YoY Growth 2016-2027
7.2 North America Mesalazine Market Facts & Figures by Country
7.2.1 North America Mesalazine Sales by Country (2016-2021)
7.2.2 North America Mesalazine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Mesalazine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Mesalazine Market Facts & Figures by Region
8.2.1 Asia Pacific Mesalazine Sales by Region (2016-2021)
8.2.2 Asia Pacific Mesalazine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Mesalazine Market Size YoY Growth 2016-2027
9.2 Europe Mesalazine Market Facts & Figures by Country
9.2.1 Europe Mesalazine Sales by Country (2016-2021)
9.2.2 Europe Mesalazine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Mesalazine Market Size YoY Growth 2016-2027
10.2 Latin America Mesalazine Market Facts & Figures by Country
10.2.1 Latin America Mesalazine Sales by Country (2016-2021)
10.2.2 Latin America Mesalazine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Mesalazine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Mesalazine Market Facts & Figures by Country
11.2.1 Middle East and Africa Mesalazine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Mesalazine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 PharmaZell
12.1.1 PharmaZell Corporation Information
12.1.2 PharmaZell Description and Business Overview
12.1.3 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 PharmaZell Mesalazine Products Offered
12.1.5 PharmaZell Recent Development
12.2 Syntese A/S
12.2.1 Syntese A/S Corporation Information
12.2.2 Syntese A/S Description and Business Overview
12.2.3 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Syntese A/S Mesalazine Products Offered
12.2.5 Syntese A/S Recent Development
12.3 Cambrex Corporation
12.3.1 Cambrex Corporation Corporation Information
12.3.2 Cambrex Corporation Description and Business Overview
12.3.3 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Cambrex Corporation Mesalazine Products Offered
12.3.5 Cambrex Corporation Recent Development
12.4 Divis Laboratories
12.4.1 Divis Laboratories Corporation Information
12.4.2 Divis Laboratories Description and Business Overview
12.4.3 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Divis Laboratories Mesalazine Products Offered
12.4.5 Divis Laboratories Recent Development
12.5 Chemi SpA
12.5.1 Chemi SpA Corporation Information
12.5.2 Chemi SpA Description and Business Overview
12.5.3 Chemi SpA Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Chemi SpA Mesalazine Products Offered
12.5.5 Chemi SpA Recent Development
12.6 Ipca Laboratories
12.6.1 Ipca Laboratories Corporation Information
12.6.2 Ipca Laboratories Description and Business Overview
12.6.3 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ipca Laboratories Mesalazine Products Offered
12.6.5 Ipca Laboratories Recent Development
12.7 Hangzhou Brother
12.7.1 Hangzhou Brother Corporation Information
12.7.2 Hangzhou Brother Description and Business Overview
12.7.3 Hangzhou Brother Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hangzhou Brother Mesalazine Products Offered
12.7.5 Hangzhou Brother Recent Development
12.8 Lianyungang Fengheng Biopharm
12.8.1 Lianyungang Fengheng Biopharm Corporation Information
12.8.2 Lianyungang Fengheng Biopharm Description and Business Overview
12.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Lianyungang Fengheng Biopharm Mesalazine Products Offered
12.8.5 Lianyungang Fengheng Biopharm Recent Development
12.9 Lasa Loboratory
12.9.1 Lasa Loboratory Corporation Information
12.9.2 Lasa Loboratory Description and Business Overview
12.9.3 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Lasa Loboratory Mesalazine Products Offered
12.9.5 Lasa Loboratory Recent Development
12.10 Corden Pharma Bergamo
12.10.1 Corden Pharma Bergamo Corporation Information
12.10.2 Corden Pharma Bergamo Description and Business Overview
12.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Corden Pharma Bergamo Mesalazine Products Offered
12.10.5 Corden Pharma Bergamo Recent Development
12.11 PharmaZell
12.11.1 PharmaZell Corporation Information
12.11.2 PharmaZell Description and Business Overview
12.11.3 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 PharmaZell Mesalazine Products Offered
12.11.5 PharmaZell Recent Development
12.12 CTX Lifescience
12.12.1 CTX Lifescience Corporation Information
12.12.2 CTX Lifescience Description and Business Overview
12.12.3 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 CTX Lifescience Products Offered
12.12.5 CTX Lifescience Recent Development
12.13 Ishita Active Pharma Ingredients
12.13.1 Ishita Active Pharma Ingredients Corporation Information
12.13.2 Ishita Active Pharma Ingredients Description and Business Overview
12.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Ishita Active Pharma Ingredients Products Offered
12.13.5 Ishita Active Pharma Ingredients Recent Development
12.14 YC Biotech (Jiangsu)
12.14.1 YC Biotech (Jiangsu) Corporation Information
12.14.2 YC Biotech (Jiangsu) Description and Business Overview
12.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 YC Biotech (Jiangsu) Products Offered
12.14.5 YC Biotech (Jiangsu) Recent Development
12.15 Xinxiang Tianfeng Fine Chemical
12.15.1 Xinxiang Tianfeng Fine Chemical Corporation Information
12.15.2 Xinxiang Tianfeng Fine Chemical Description and Business Overview
12.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Xinxiang Tianfeng Fine Chemical Products Offered
12.15.5 Xinxiang Tianfeng Fine Chemical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Mesalazine Industry Trends
13.2 Mesalazine Market Drivers
13.3 Mesalazine Market Challenges
13.4 Mesalazine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mesalazine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Mesalazine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity ≥ 97 %
Table 3. Major Manufacturers of Purity ≥ 98 %
Table 4. Major Manufacturers of Purity ≥ 99 %
Table 5. Global Mesalazine Market Size Growth Rate by Application (2021-2027) & (Ton)
Table 6. Global Mesalazine Market Size by Region (Ton) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Mesalazine Sales by Regions (2016-2021) & (Ton)
Table 8. Global Mesalazine Sales Market Share by Regions (2016-2021)
Table 9. Global Mesalazine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Mesalazine Sales Forecast by Region (2022-2027) & (Ton)
Table 11. Global Mesalazine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Mesalazine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Mesalazine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Mesalazine Sales by Manufacturers (2016-2021) (Ton)
Table 15. Global Mesalazine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Mesalazine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Mesalazine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Mesalazine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Mesalazine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Mesalazine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalazine as of 2020)
Table 21. Key Manufacturers Mesalazine Price (2016-2021) (US$/Kg)
Table 22. Mesalazine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Mesalazine Product Type
Table 24. Date of International Manufacturers Enter into Mesalazine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Mesalazine Sales by Type (2016-2021) (Ton)
Table 27. Global Mesalazine Sales Share by Type (2016-2021)
Table 28. Global Mesalazine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Mesalazine Revenue Share by Type (2016-2021)
Table 30. Mesalazine Average Selling Price (ASP) by Type (2016-2021) & (US$/Kg)
Table 31. Global Mesalazine Sales Forecast by Type (2022-2027) & (Ton)
Table 32. Global Mesalazine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Mesalazine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Mesalazine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Mesalazine Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Kg)
Table 36. Global Mesalazine Sales by Application (2016-2021) (Ton)
Table 37. Global Mesalazine Sales Share by Application (2016-2021)
Table 38. Global Mesalazine Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Mesalazine Revenue Share by Application (2016-2021)
Table 40. Mesalazine Average Selling Price (ASP) by Application (2016-2021) & (US$/Kg)
Table 41. Global Mesalazine Sales Forecast by Application (2022-2027) & (Ton)
Table 42. Global Mesalazine Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Mesalazine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Mesalazine Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Mesalazine Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Kg)
Table 46. China Mesalazine Sales (Ton) of Key Companies (2016-2021)
Table 47. China Mesalazine Sales Share by Company (2016-2021)
Table 48. China Mesalazine Revenue (US$ Million) by Company (2016-2021)
Table 49. China Mesalazine Revenue Share by Company (2016-2021)
Table 50. China Mesalazine Sales (Ton) by Type (2016-2021)
Table 51. China Mesalazine Sales Share by Type (2016-2021)
Table 52. China Mesalazine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Mesalazine Price (US$/Kg) by Type (2016-2021)
Table 54. China Mesalazine Sales (Ton) by Type (2022-2027)
Table 55. China Mesalazine Sales Share by Type (2022-2027)
Table 56. China Mesalazine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Mesalazine Revenue Share by Type (2022-2027)
Table 58. China Mesalazine Price (US$/Kg) by Type (2022-2027)
Table 59. China Mesalazine Sales (Ton) by Application (2016-2021)
Table 60. China Mesalazine Sales Share by Application (2016-2021)
Table 61. China Mesalazine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Mesalazine Price (US$/Kg) by Application (2016-2021)
Table 63. China Mesalazine Sales (Ton) by Application (2022-2027)
Table 64. China Mesalazine Sales Share by Application (2022-2027)
Table 65. China Mesalazine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Mesalazine Revenue Share by Application (2022-2027)
Table 67. China Mesalazine Price (US$/Kg) by Application (2022-2027)
Table 68. North America Mesalazine Sales by Country (2016-2021) & (Ton)
Table 69. North America Mesalazine Sales Market Share by Country (2016-2021)
Table 70. North America Mesalazine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Mesalazine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Mesalazine Sales by Region (2016-2021) & (Ton)
Table 73. Asia Pacific Mesalazine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Mesalazine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Mesalazine Revenue Market Share by Region (2016-2021)
Table 76. Europe Mesalazine Sales by Country (2016-2021) & (Ton)
Table 77. Europe Mesalazine Sales Market Share by Country (2016-2021)
Table 78. Europe Mesalazine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Mesalazine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Mesalazine Sales by Country (2016-2021) & (Ton)
Table 81. Latin America Mesalazine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Mesalazine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Mesalazine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Mesalazine Sales by Country (2016-2021) & (Ton)
Table 85. Middle East and Africa Mesalazine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Mesalazine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Mesalazine Revenue Market Share by Country (2016-2021)
Table 88. PharmaZell Corporation Information
Table 89. PharmaZell Description and Business Overview
Table 90. PharmaZell Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 91. PharmaZell Mesalazine Product
Table 92. PharmaZell Recent Development
Table 93. Syntese A/S Corporation Information
Table 94. Syntese A/S Description and Business Overview
Table 95. Syntese A/S Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 96. Syntese A/S Product
Table 97. Syntese A/S Recent Development
Table 98. Cambrex Corporation Corporation Information
Table 99. Cambrex Corporation Description and Business Overview
Table 100. Cambrex Corporation Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 101. Cambrex Corporation Product
Table 102. Cambrex Corporation Recent Development
Table 103. Divis Laboratories Corporation Information
Table 104. Divis Laboratories Description and Business Overview
Table 105. Divis Laboratories Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 106. Divis Laboratories Product
Table 107. Divis Laboratories Recent Development
Table 108. Chemi SpA Corporation Information
Table 109. Chemi SpA Description and Business Overview
Table 110. Chemi SpA Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 111. Chemi SpA Product
Table 112. Chemi SpA Recent Development
Table 113. Ipca Laboratories Corporation Information
Table 114. Ipca Laboratories Description and Business Overview
Table 115. Ipca Laboratories Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 116. Ipca Laboratories Product
Table 117. Ipca Laboratories Recent Development
Table 118. Hangzhou Brother Corporation Information
Table 119. Hangzhou Brother Description and Business Overview
Table 120. Hangzhou Brother Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 121. Hangzhou Brother Product
Table 122. Hangzhou Brother Recent Development
Table 123. Lianyungang Fengheng Biopharm Corporation Information
Table 124. Lianyungang Fengheng Biopharm Description and Business Overview
Table 125. Lianyungang Fengheng Biopharm Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 126. Lianyungang Fengheng Biopharm Product
Table 127. Lianyungang Fengheng Biopharm Recent Development
Table 128. Lasa Loboratory Corporation Information
Table 129. Lasa Loboratory Description and Business Overview
Table 130. Lasa Loboratory Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 131. Lasa Loboratory Product
Table 132. Lasa Loboratory Recent Development
Table 133. Corden Pharma Bergamo Corporation Information
Table 134. Corden Pharma Bergamo Description and Business Overview
Table 135. Corden Pharma Bergamo Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 136. Corden Pharma Bergamo Product
Table 137. Corden Pharma Bergamo Recent Development
Table 138. Erregierre SpA Corporation Information
Table 139. Erregierre SpA Description and Business Overview
Table 140. Erregierre SpA Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 141. Erregierre SpA Product
Table 142. Erregierre SpA Recent Development
Table 143. CTX Lifescience Corporation Information
Table 144. CTX Lifescience Description and Business Overview
Table 145. CTX Lifescience Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 146. CTX Lifescience Product
Table 147. CTX Lifescience Recent Development
Table 148. Ishita Active Pharma Ingredients Corporation Information
Table 149. Ishita Active Pharma Ingredients Description and Business Overview
Table 150. Ishita Active Pharma Ingredients Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 151. Ishita Active Pharma Ingredients Product
Table 152. Ishita Active Pharma Ingredients Recent Development
Table 153. YC Biotech (Jiangsu) Corporation Information
Table 154. YC Biotech (Jiangsu) Description and Business Overview
Table 155. YC Biotech (Jiangsu) Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 156. YC Biotech (Jiangsu) Product
Table 157. YC Biotech (Jiangsu) Recent Development
Table 158. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 159. Xinxiang Tianfeng Fine Chemical Description and Business Overview
Table 160. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 161. Xinxiang Tianfeng Fine Chemical Product
Table 162. Xinxiang Tianfeng Fine Chemical Recent Development
Table 163. Mesalazine Market Trends
Table 164. Mesalazine Market Drivers
Table 165. Mesalazine Market Challenges
Table 166. Mesalazine Market Restraints
Table 167. Mesalazine Customers List
Table 168. Mesalazine Distributors List
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Mesalazine Product Picture
Figure 2. Global Mesalazine Sales Market Share by Type in 2020 & 2027
Figure 3. Purity ≥ 97 % Product Picture
Figure 4. Purity ≥ 98 % Product Picture
Figure 5. Purity ≥ 99 % Product Picture
Figure 6. Global Mesalazine Sales Market Share by Application in 2020 & 2027
Figure 7. Tablets
Figure 8. Capsules
Figure 9. Pellet and Granule
Figure 10. Suppository
Figure 11. Enema
Figure 12. Others
Figure 13. Mesalazine Report Years Considered
Figure 14. Global Mesalazine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Mesalazine Market Size 2016-2027 (US$ Million)
Figure 16. Global Mesalazine Sales 2016-2027 (Ton)
Figure 17. Global Mesalazine Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global Mesalazine Sales Market Share by Region (2016-2021)
Figure 19. Global Mesalazine Sales Market Share by Region in 2020
Figure 20. Global Mesalazine Revenue Market Share by Region (2016-2021)
Figure 21. Global Mesalazine Revenue Market Share by Region in 2020
Figure 22. Global Mesalazine Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by Mesalazine Revenue in 2020
Figure 24. Mesalazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global Mesalazine Sales Market Share by Type (2016-2021)
Figure 26. Global Mesalazine Sales Market Share by Type in 2020
Figure 27. Global Mesalazine Revenue Market Share by Type (2016-2021)
Figure 28. Global Mesalazine Revenue Market Share by Type in 2020
Figure 29. Global Mesalazine Sales Market Share by Application (2016-2021)
Figure 30. Global Mesalazine Sales Market Share by Application in 2020
Figure 31. Global Mesalazine Revenue Market Share by Application (2016-2021)
Figure 32. Global Mesalazine Revenue Market Share by Application in 2020
Figure 33. China Mesalazine Sales Growth Rate 2016-2027 (Ton)
Figure 34. China Mesalazine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. China Mesalazine Market Share in Global Market 2016-2027
Figure 36. China 5 and 10 Largest Mesalazine Players Market Share by Revenue in Mesalazine in 2020
Figure 37. China Mesalazine Revenue Share by Type (2016-2021)
Figure 38. China Mesalazine Revenue Growth Rate by Type in 2016 & 2020
Figure 39. China Mesalazine Revenue Share by Application (2016-2021)
Figure 40. China Mesalazine Revenue Growth Rate by Application in 2016 & 2020
Figure 41. North America Mesalazine Sales Growth Rate 2016-2021 (Ton)
Figure 42. North America Mesalazine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 43. North America Mesalazine Sales Market Share by Country in 2020
Figure 44. North America Mesalazine Revenue Market Share by Country in 2020
Figure 45. U.S. Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 46. U.S. Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Canada Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 48. Canada Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Europe Mesalazine Sales Growth Rate 2016-2021 (Ton)
Figure 50. Europe Mesalazine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 51. Europe Mesalazine Sales Market Share by Country in 2020
Figure 52. Europe Mesalazine Revenue Market Share by Country in 2020
Figure 53. Germany Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 54. Germany Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. France Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 56. France Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. U.K. Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 58. U.K. Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Italy Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 60. Italy Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Russia Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 62. Russia Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Asia Pacific Mesalazine Sales Growth Rate 2016-2021 (Ton)
Figure 64. Asia Pacific Mesalazine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 65. Asia Pacific Mesalazine Sales Market Share by Region in 2020
Figure 66. Asia Pacific Mesalazine Revenue Market Share by Region in 2020
Figure 67. China Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 68. China Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Japan Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 70. Japan Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. South Korea Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 72. South Korea Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. India Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 74. India Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Australia Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 76. Australia Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Taiwan Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 78. Taiwan Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Indonesia Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 80. Indonesia Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Thailand Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 82. Thailand Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Malaysia Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 84. Malaysia Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Philippines Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 86. Philippines Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Vietnam Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 88. Vietnam Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Latin America Mesalazine Sales Growth Rate 2016-2021 (Ton)
Figure 90. Latin America Mesalazine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 91. Latin America Mesalazine Sales Market Share by Country in 2020
Figure 92. Latin America Mesalazine Revenue Market Share by Country in 2020
Figure 93. Mexico Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 94. Mexico Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Brazil Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 96. Brazil Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Argentina Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 98. Argentina Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Middle East and Africa Mesalazine Sales Growth Rate 2016-2021 (Ton)
Figure 100. Middle East and Africa Mesalazine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 101. Middle East and Africa Mesalazine Sales Market Share by Country in 2020
Figure 102. Middle East and Africa Mesalazine Revenue Market Share by Country in 2020
Figure 103. Turkey Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 104. Turkey Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Saudi Arabia Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 106. Saudi Arabia Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. UAE Mesalazine Sales Growth Rate (2016-2021) (Ton)
Figure 108. UAE Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. Mesalazine Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed